Xanthe Cerutti
Papers
1
Total Citations
13
H-Index
1
About
Dr. Xanthe Cerutti is a pioneering cancer immunologist whose work bridges the gap between local tumor ablation and systemic immune activation. Her primary research focuses on the immunomodulatory effects of irreversible electroporation (IRE) in prostate cancer, a field where she has made transformative contributions. In her landmark 2024 study, the IRE-IMMUNO trial, Dr. Cerutti demonstrated that IRE not only destroys localized prostate tumors but also downregulates immune suppression and induces systemic anti-tumor T-cell activation—a finding with profound implications for combination immunotherapy. This work, already garnering 13 citations, positions her at the forefront of immuno-oncology and interventional oncology. By prospectively comparing IRE to robot-assisted radical prostatectomy, she provided the first rigorous evidence that focal ablation can trigger a whole-body immune response, challenging conventional treatment paradigms. Dr. Cerutti’s research is reshaping how clinicians think about the immune consequences of local therapies, opening new avenues for harnessing the body’s defenses against cancer. Her innovative approach and high-impact findings mark her as a rising leader in the quest for more effective, less invasive cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1